nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyltestosterone—CYP2B6—Thiotepa—sarcoma	0.416	0.539	CbGbCtD
Methyltestosterone—CYP3A4—Thiotepa—sarcoma	0.128	0.166	CbGbCtD
Methyltestosterone—CYP2B6—Doxorubicin—sarcoma	0.077	0.0997	CbGbCtD
Methyltestosterone—CYP3A4—Mitoxantrone—sarcoma	0.055	0.0712	CbGbCtD
Methyltestosterone—CYP3A4—Vincristine—sarcoma	0.0379	0.049	CbGbCtD
Methyltestosterone—CYP3A4—Etoposide—sarcoma	0.0347	0.0449	CbGbCtD
Methyltestosterone—AR—scrotum—sarcoma	0.0237	0.237	CbGeAlD
Methyltestosterone—CYP3A4—Doxorubicin—sarcoma	0.0237	0.0306	CbGbCtD
Methyltestosterone—SHBG—hindlimb—sarcoma	0.0113	0.112	CbGeAlD
Methyltestosterone—Azoospermia—Thiotepa—sarcoma	0.0112	0.111	CcSEcCtD
Methyltestosterone—Oligospermia—Epirubicin—sarcoma	0.00579	0.0574	CcSEcCtD
Methyltestosterone—Oligospermia—Doxorubicin—sarcoma	0.00536	0.0531	CcSEcCtD
Methyltestosterone—Azoospermia—Epirubicin—sarcoma	0.00451	0.0447	CcSEcCtD
Methyltestosterone—Azoospermia—Doxorubicin—sarcoma	0.00417	0.0413	CcSEcCtD
Methyltestosterone—Venous thromboembolism—Epirubicin—sarcoma	0.00413	0.0409	CcSEcCtD
Methyltestosterone—ALB—mammary gland—sarcoma	0.00388	0.0388	CbGeAlD
Methyltestosterone—Coagulopathy—Dactinomycin—sarcoma	0.00384	0.0381	CcSEcCtD
Methyltestosterone—Venous thromboembolism—Doxorubicin—sarcoma	0.00382	0.0379	CcSEcCtD
Methyltestosterone—Amenorrhoea—Thiotepa—sarcoma	0.00343	0.034	CcSEcCtD
Methyltestosterone—Amenorrhoea—Mitoxantrone—sarcoma	0.00296	0.0294	CcSEcCtD
Methyltestosterone—SHBG—hematopoietic system—sarcoma	0.00286	0.0286	CbGeAlD
Methyltestosterone—SHBG—connective tissue—sarcoma	0.00276	0.0275	CbGeAlD
Methyltestosterone—SHBG—Nongenotropic Androgen signaling—PLCG1—sarcoma	0.00251	0.0951	CbGpPWpGaD
Methyltestosterone—Embolism venous—Epirubicin—sarcoma	0.00241	0.0238	CcSEcCtD
Methyltestosterone—AR—myometrium—sarcoma	0.00239	0.0239	CbGeAlD
Methyltestosterone—SLCO1A2—hematopoietic system—sarcoma	0.00238	0.0238	CbGeAlD
Methyltestosterone—CYP19A1—hematopoietic system—sarcoma	0.00232	0.0232	CbGeAlD
Methyltestosterone—SLC22A8—hematopoietic system—sarcoma	0.00227	0.0227	CbGeAlD
Methyltestosterone—CYP19A1—connective tissue—sarcoma	0.00223	0.0223	CbGeAlD
Methyltestosterone—Embolism venous—Doxorubicin—sarcoma	0.00223	0.0221	CcSEcCtD
Methyltestosterone—SHBG—uterus—sarcoma	0.00216	0.0216	CbGeAlD
Methyltestosterone—AR—seminal vesicle—sarcoma	0.00216	0.0216	CbGeAlD
Methyltestosterone—AR—hematopoietic system—sarcoma	0.00205	0.0205	CbGeAlD
Methyltestosterone—AR—connective tissue—sarcoma	0.00198	0.0198	CbGeAlD
Methyltestosterone—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00195	0.0194	CcSEcCtD
Methyltestosterone—SHBG—bone marrow—sarcoma	0.00184	0.0183	CbGeAlD
Methyltestosterone—AR—smooth muscle tissue—sarcoma	0.00181	0.0181	CbGeAlD
Methyltestosterone—AR—skin of body—sarcoma	0.00179	0.0178	CbGeAlD
Methyltestosterone—CYP19A1—uterus—sarcoma	0.00175	0.0175	CbGeAlD
Methyltestosterone—Anaphylactoid reaction—Etoposide—sarcoma	0.00162	0.0161	CcSEcCtD
Methyltestosterone—SHBG—testis—sarcoma	0.00157	0.0157	CbGeAlD
Methyltestosterone—AR—cardiac atrium—sarcoma	0.00156	0.0156	CbGeAlD
Methyltestosterone—AR—uterus—sarcoma	0.00155	0.0155	CbGeAlD
Methyltestosterone—Haemoglobin—Thiotepa—sarcoma	0.00152	0.0151	CcSEcCtD
Methyltestosterone—Haemorrhage—Thiotepa—sarcoma	0.00151	0.015	CcSEcCtD
Methyltestosterone—CYP2B6—hematopoietic system—sarcoma	0.00149	0.0149	CbGeAlD
Methyltestosterone—SHBG—liver—sarcoma	0.00148	0.0148	CbGeAlD
Methyltestosterone—AR—lymphoid tissue—sarcoma	0.00145	0.0145	CbGeAlD
Methyltestosterone—Jaundice cholestatic—Epirubicin—sarcoma	0.00138	0.0137	CcSEcCtD
Methyltestosterone—Amenorrhoea—Epirubicin—sarcoma	0.00138	0.0137	CcSEcCtD
Methyltestosterone—Angiopathy—Thiotepa—sarcoma	0.00137	0.0136	CcSEcCtD
Methyltestosterone—AR—tendon—sarcoma	0.00136	0.0136	CbGeAlD
Methyltestosterone—Alopecia—Thiotepa—sarcoma	0.00134	0.0133	CcSEcCtD
Methyltestosterone—Alopecia—Dactinomycin—sarcoma	0.00133	0.0132	CcSEcCtD
Methyltestosterone—Haemoglobin—Mitoxantrone—sarcoma	0.00131	0.013	CcSEcCtD
Methyltestosterone—Haemorrhage—Mitoxantrone—sarcoma	0.00131	0.013	CcSEcCtD
Methyltestosterone—SLCO1A2—testis—sarcoma	0.0013	0.013	CbGeAlD
Methyltestosterone—CYP2B6—skin of body—sarcoma	0.0013	0.0129	CbGeAlD
Methyltestosterone—ALB—testis—sarcoma	0.0013	0.0129	CbGeAlD
Methyltestosterone—SHBG—Nongenotropic Androgen signaling—CREB1—sarcoma	0.00129	0.049	CbGpPWpGaD
Methyltestosterone—Amenorrhoea—Doxorubicin—sarcoma	0.00128	0.0127	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Doxorubicin—sarcoma	0.00128	0.0127	CcSEcCtD
Methyltestosterone—CYP19A1—testis—sarcoma	0.00127	0.0127	CbGeAlD
Methyltestosterone—CYP19A1—Ovarian Infertility Genes—GJA4—sarcoma	0.00127	0.0481	CbGpPWpGaD
Methyltestosterone—SLCO1A2—liver—sarcoma	0.00123	0.0123	CbGeAlD
Methyltestosterone—ALB—liver—sarcoma	0.00122	0.0122	CbGeAlD
Methyltestosterone—Angiopathy—Vincristine—sarcoma	0.00122	0.0121	CcSEcCtD
Methyltestosterone—CYP19A1—liver—sarcoma	0.0012	0.012	CbGeAlD
Methyltestosterone—Alopecia—Vincristine—sarcoma	0.00119	0.0118	CcSEcCtD
Methyltestosterone—Alopecia—Mitoxantrone—sarcoma	0.00116	0.0114	CcSEcCtD
Methyltestosterone—AR—testis—sarcoma	0.00113	0.0112	CbGeAlD
Methyltestosterone—CYP3A4—hematopoietic system—sarcoma	0.00113	0.0112	CbGeAlD
Methyltestosterone—Anxiety—Thiotepa—sarcoma	0.00112	0.0111	CcSEcCtD
Methyltestosterone—AR—liver—sarcoma	0.00106	0.0106	CbGeAlD
Methyltestosterone—CYP2B6—lymphoid tissue—sarcoma	0.00105	0.0105	CbGeAlD
Methyltestosterone—AR—FOXA1 transcription factor network—COL18A1—sarcoma	0.000988	0.0374	CbGpPWpGaD
Methyltestosterone—Angiopathy—Etoposide—sarcoma	0.000987	0.00978	CcSEcCtD
Methyltestosterone—Paraesthesia—Thiotepa—sarcoma	0.000966	0.00957	CcSEcCtD
Methyltestosterone—Anxiety—Mitoxantrone—sarcoma	0.000966	0.00957	CcSEcCtD
Methyltestosterone—Alopecia—Etoposide—sarcoma	0.000961	0.00952	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Vincristine—sarcoma	0.000954	0.00945	CcSEcCtD
Methyltestosterone—ALB—lymph node—sarcoma	0.000939	0.00938	CbGeAlD
Methyltestosterone—Anaphylactic shock—Mitoxantrone—sarcoma	0.000929	0.00921	CcSEcCtD
Methyltestosterone—CYP19A1—lymph node—sarcoma	0.000922	0.00921	CbGeAlD
Methyltestosterone—Anaphylactoid reaction—Epirubicin—sarcoma	0.000911	0.00902	CcSEcCtD
Methyltestosterone—Paraesthesia—Vincristine—sarcoma	0.000857	0.00849	CcSEcCtD
Methyltestosterone—ALB—Scavenging of heme from plasma—HBA1—sarcoma	0.00085	0.0322	CbGpPWpGaD
Methyltestosterone—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000843	0.00835	CcSEcCtD
Methyltestosterone—AR—Notch-mediated HES/HEY network—TLE1—sarcoma	0.000842	0.0318	CbGpPWpGaD
Methyltestosterone—SHBG—Nongenotropic Androgen signaling—SRC—sarcoma	0.000835	0.0316	CbGpPWpGaD
Methyltestosterone—Paraesthesia—Mitoxantrone—sarcoma	0.000834	0.00827	CcSEcCtD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYOG—sarcoma	0.000834	0.0316	CbGpPWpGaD
Methyltestosterone—CYP2B6—testis—sarcoma	0.000817	0.00816	CbGeAlD
Methyltestosterone—AR—lymph node—sarcoma	0.000816	0.00815	CbGeAlD
Methyltestosterone—AR—Notch-mediated HES/HEY network—MYOD1—sarcoma	0.000789	0.0298	CbGpPWpGaD
Methyltestosterone—AR—Nongenotropic Androgen signaling—PLCG1—sarcoma	0.000778	0.0295	CbGpPWpGaD
Methyltestosterone—Anaphylactic shock—Etoposide—sarcoma	0.000773	0.00766	CcSEcCtD
Methyltestosterone—CYP2B6—liver—sarcoma	0.000772	0.00771	CbGeAlD
Methyltestosterone—Paraesthesia—Etoposide—sarcoma	0.000694	0.00688	CcSEcCtD
Methyltestosterone—Headache—Thiotepa—sarcoma	0.000674	0.00668	CcSEcCtD
Methyltestosterone—Nausea—Thiotepa—sarcoma	0.000639	0.00633	CcSEcCtD
Methyltestosterone—Nausea—Dactinomycin—sarcoma	0.000634	0.00628	CcSEcCtD
Methyltestosterone—Haemoglobin—Epirubicin—sarcoma	0.000613	0.00607	CcSEcCtD
Methyltestosterone—Haemorrhage—Epirubicin—sarcoma	0.00061	0.00604	CcSEcCtD
Methyltestosterone—Headache—Vincristine—sarcoma	0.000598	0.00592	CcSEcCtD
Methyltestosterone—SHBG—Nongenotropic Androgen signaling—HRAS—sarcoma	0.000587	0.0222	CbGpPWpGaD
Methyltestosterone—CYP3A4—liver—sarcoma	0.000583	0.00583	CbGeAlD
Methyltestosterone—Headache—Mitoxantrone—sarcoma	0.000582	0.00577	CcSEcCtD
Methyltestosterone—Haemoglobin—Doxorubicin—sarcoma	0.000567	0.00562	CcSEcCtD
Methyltestosterone—Nausea—Vincristine—sarcoma	0.000567	0.00561	CcSEcCtD
Methyltestosterone—Haemorrhage—Doxorubicin—sarcoma	0.000564	0.00559	CcSEcCtD
Methyltestosterone—Angiopathy—Epirubicin—sarcoma	0.000553	0.00548	CcSEcCtD
Methyltestosterone—Nausea—Mitoxantrone—sarcoma	0.000552	0.00547	CcSEcCtD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TLE1—sarcoma	0.00055	0.0208	CbGpPWpGaD
Methyltestosterone—Alopecia—Epirubicin—sarcoma	0.000539	0.00534	CcSEcCtD
Methyltestosterone—CYP19A1—FSH signaling pathway—FOXO1—sarcoma	0.000531	0.0201	CbGpPWpGaD
Methyltestosterone—Angiopathy—Doxorubicin—sarcoma	0.000512	0.00507	CcSEcCtD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—MYOD1—sarcoma	0.00051	0.0193	CbGpPWpGaD
Methyltestosterone—Alopecia—Doxorubicin—sarcoma	0.000499	0.00494	CcSEcCtD
Methyltestosterone—Headache—Etoposide—sarcoma	0.000484	0.0048	CcSEcCtD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MITF—sarcoma	0.000479	0.0181	CbGpPWpGaD
Methyltestosterone—Nausea—Etoposide—sarcoma	0.000459	0.00455	CcSEcCtD
Methyltestosterone—Anxiety—Epirubicin—sarcoma	0.00045	0.00446	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Epirubicin—sarcoma	0.000433	0.00429	CcSEcCtD
Methyltestosterone—Anxiety—Doxorubicin—sarcoma	0.000417	0.00413	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Doxorubicin—sarcoma	0.000401	0.00397	CcSEcCtD
Methyltestosterone—AR—Nongenotropic Androgen signaling—CREB1—sarcoma	0.000401	0.0152	CbGpPWpGaD
Methyltestosterone—Paraesthesia—Epirubicin—sarcoma	0.000389	0.00385	CcSEcCtD
Methyltestosterone—CYP19A1—FSH signaling pathway—CREB1—sarcoma	0.000385	0.0146	CbGpPWpGaD
Methyltestosterone—Paraesthesia—Doxorubicin—sarcoma	0.00036	0.00357	CcSEcCtD
Methyltestosterone—AR—Regulation of Androgen receptor activity—FOXO1—sarcoma	0.00036	0.0136	CbGpPWpGaD
Methyltestosterone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—HBA1—sarcoma	0.000339	0.0128	CbGpPWpGaD
Methyltestosterone—AR—Notch-mediated HES/HEY network—KDR—sarcoma	0.000327	0.0124	CbGpPWpGaD
Methyltestosterone—CYP2B6—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000298	0.0113	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—HBA1—sarcoma	0.000285	0.0108	CbGpPWpGaD
Methyltestosterone—Headache—Epirubicin—sarcoma	0.000271	0.00269	CcSEcCtD
Methyltestosterone—AR—Nongenotropic Androgen signaling—SRC—sarcoma	0.000258	0.00978	CbGpPWpGaD
Methyltestosterone—Nausea—Epirubicin—sarcoma	0.000257	0.00255	CcSEcCtD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—FOXO1—sarcoma	0.000256	0.00969	CbGpPWpGaD
Methyltestosterone—Headache—Doxorubicin—sarcoma	0.000251	0.00249	CcSEcCtD
Methyltestosterone—CYP19A1—FSH signaling pathway—SRC—sarcoma	0.000248	0.0094	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000239	0.00904	CbGpPWpGaD
Methyltestosterone—Nausea—Doxorubicin—sarcoma	0.000238	0.00236	CcSEcCtD
Methyltestosterone—AR—Androgen receptor signaling pathway—FOXO1—sarcoma	0.000238	0.00899	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—HBA1—sarcoma	0.000232	0.00877	CbGpPWpGaD
Methyltestosterone—AR—FOXA1 transcription factor network—JUN—sarcoma	0.000218	0.00824	CbGpPWpGaD
Methyltestosterone—ALB—Platelet degranulation—VEGFC—sarcoma	0.000216	0.00817	CbGpPWpGaD
Methyltestosterone—AR—Regulation of Androgen receptor activity—MDM2—sarcoma	0.000216	0.00817	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.000208	0.00788	CbGpPWpGaD
Methyltestosterone—CYP19A1—Tryptophan metabolism—MDM2—sarcoma	0.000208	0.00787	CbGpPWpGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFC—sarcoma	0.000206	0.00778	CbGpPWpGaD
Methyltestosterone—AR—Regulation of Androgen receptor activity—JUN—sarcoma	0.000188	0.0071	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—CREB1—sarcoma	0.000186	0.00703	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—HBA1—sarcoma	0.000184	0.00696	CbGpPWpGaD
Methyltestosterone—AR—Nongenotropic Androgen signaling—HRAS—sarcoma	0.000182	0.00688	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.000179	0.00678	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—sarcoma	0.000175	0.00661	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—CREB1—sarcoma	0.000172	0.00652	CbGpPWpGaD
Methyltestosterone—AR—Regulation of Androgen receptor activity—SRC—sarcoma	0.000168	0.00637	CbGpPWpGaD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—CCND1—sarcoma	0.000168	0.00636	CbGpPWpGaD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—CTNNB1—sarcoma	0.000166	0.00629	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—FOXO1—sarcoma	0.000156	0.00589	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—MDM2—sarcoma	0.000143	0.00539	CbGpPWpGaD
Methyltestosterone—ALB—FOXA2 and FOXA3 transcription factor networks—CREB1—sarcoma	0.000141	0.00533	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—sarcoma	0.000135	0.00512	CbGpPWpGaD
Methyltestosterone—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000135	0.00512	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—sarcoma	0.000135	0.00511	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—FOXO1—sarcoma	0.000134	0.00507	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—sarcoma	0.000134	0.00507	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	0.000134	0.00506	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000127	0.0048	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—CCND1—sarcoma	0.000124	0.0047	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—JUN—sarcoma	0.000124	0.00469	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—CTNNB1—sarcoma	0.000123	0.00465	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.000113	0.00427	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—SRC—sarcoma	0.000111	0.00421	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—CREB1—sarcoma	0.00011	0.00416	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—sarcoma	0.000108	0.0041	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	0.000107	0.00406	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—FUS—sarcoma	9.94e-05	0.00376	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—EGFR—sarcoma	9.74e-05	0.00369	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CREB1—sarcoma	9.71e-05	0.00368	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—VEGFC—sarcoma	9.57e-05	0.00362	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	9.35e-05	0.00354	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—MDM2—sarcoma	9.34e-05	0.00353	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CCND1—sarcoma	8.13e-05	0.00308	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—JUN—sarcoma	8.12e-05	0.00307	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	8.06e-05	0.00305	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—MDM2—sarcoma	8.04e-05	0.00304	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—JUN—sarcoma	7.91e-05	0.00299	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—CTNNB1—sarcoma	7.85e-05	0.00297	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	7.74e-05	0.00293	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—IL2—sarcoma	7.53e-05	0.00285	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—VEGFA—sarcoma	7.09e-05	0.00268	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—sarcoma	7e-05	0.00265	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—JUN—sarcoma	6.98e-05	0.00264	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	6.93e-05	0.00262	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—VEGFA—sarcoma	6.91e-05	0.00261	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	6.74e-05	0.00255	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	6.73e-05	0.00255	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—TEK—sarcoma	6.72e-05	0.00254	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	6.67e-05	0.00253	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—MYC—sarcoma	6.52e-05	0.00247	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—EGFR—sarcoma	6.38e-05	0.00242	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—ANGPT2—sarcoma	6.15e-05	0.00233	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	6.1e-05	0.00231	CbGpPWpGaD
Methyltestosterone—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	6.07e-05	0.0023	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	6.03e-05	0.00228	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—KRAS—sarcoma	6.03e-05	0.00228	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	5.88e-05	0.00222	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—MYC—sarcoma	5.61e-05	0.00212	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—sarcoma	5.49e-05	0.00208	CbGpPWpGaD
Methyltestosterone—ALB—Platelet degranulation—VEGFA—sarcoma	5.48e-05	0.00208	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	5.41e-05	0.00205	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—TP53—sarcoma	5.36e-05	0.00203	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	5.29e-05	0.002	CbGpPWpGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	5.22e-05	0.00198	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—sarcoma	5.19e-05	0.00196	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	5e-05	0.00189	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—VEGFC—sarcoma	4.93e-05	0.00187	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—TP53—sarcoma	4.83e-05	0.00183	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—TP53—sarcoma	4.61e-05	0.00174	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	4.44e-05	0.00168	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PLCG1—sarcoma	3.88e-05	0.00147	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—ENO2—sarcoma	3.79e-05	0.00144	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—HBA1—sarcoma	3.77e-05	0.00143	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—ENO2—sarcoma	3.43e-05	0.0013	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—HBA1—sarcoma	3.41e-05	0.00129	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PLCG1—sarcoma	3.22e-05	0.00122	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PLCG1—sarcoma	2.91e-05	0.0011	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—IL2—sarcoma	2.86e-05	0.00108	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—MYC—sarcoma	2.69e-05	0.00102	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—SRC—sarcoma	2.5e-05	0.000945	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—VEGFA—sarcoma	2.43e-05	0.00092	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ENO2—sarcoma	2.2e-05	0.000833	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—HBA1—sarcoma	2.19e-05	0.000828	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PLCG1—sarcoma	1.87e-05	0.000707	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ENO2—sarcoma	1.85e-05	0.000701	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—HBA1—sarcoma	1.84e-05	0.000697	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PLCG1—sarcoma	1.57e-05	0.000595	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IL2—sarcoma	1.48e-05	0.000558	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—MYC—sarcoma	1.29e-05	0.000489	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—SRC—sarcoma	1.29e-05	0.000487	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—VEGFA—sarcoma	1.25e-05	0.000474	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—NRAS—sarcoma	1.24e-05	0.000469	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—KRAS—sarcoma	1.07e-05	0.000403	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ENO2—sarcoma	1e-05	0.000378	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—HBA1—sarcoma	9.94e-06	0.000376	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—TP53—sarcoma	9.47e-06	0.000358	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—HRAS—sarcoma	9.06e-06	0.000343	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PLCG1—sarcoma	8.49e-06	0.000321	CbGpPWpGaD
